Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Protective effect of curcumin, silymarin and N-acetylcysteine on antitubercular drug-induced hepatotoxicity assessed in an in vitro model.

Singh M, Sasi P, Gupta VH, Rai G, Amarapurkar DN, Wangikar PP.

Hum Exp Toxicol. 2012 Aug;31(8):788-97. doi: 10.1177/0960327111433901. Epub 2012 Feb 8.

PMID:
22318308
2.

Influence of diabetes on liver injury induced by antitubercular drugs and on silymarin hepatoprotection in rats.

Srivastava RK, Sharma S, Verma S, Arora B, Lal H.

Methods Find Exp Clin Pharmacol. 2008 Dec;30(10):731-7. doi: 10.1358/mf.2008.30.10.1316824.

PMID:
19271021
3.

Protective effect of N-acetylcysteine on antituberculosis drug-induced hepatotoxicity.

Baniasadi S, Eftekhari P, Tabarsi P, Fahimi F, Raoufy MR, Masjedi MR, Velayati AA.

Eur J Gastroenterol Hepatol. 2010 Oct;22(10):1235-8. doi: 10.1097/MEG.0b013e32833aa11b.

PMID:
20461008
4.

The food supplement coenzyme Q10 and suppression of antitubercular drug-induced hepatic injury in rats: the role of antioxidant defence system, anti-inflammatory cytokine IL-10.

Baskaran UL, Sabina EP.

Cell Biol Toxicol. 2015 Oct;31(4-5):211-9. doi: 10.1007/s10565-015-9305-x. Epub 2015 Sep 15.

PMID:
26374116
5.

Antituberculosis drugs and hepatotoxicity.

Yew WW, Leung CC.

Respirology. 2006 Nov;11(6):699-707. Review.

PMID:
17052297
6.

The hepatoprotective role of Silymarin in isoniazid induced liver damage of rabbits.

Jahan S, Khan M, Imran S, Sair M.

J Pak Med Assoc. 2015 Jun;65(6):620-2.

7.

Hepatoprotective potential of Cassia auriculata roots on ethanol and antitubercular drug-induced hepatotoxicity in experimental models.

Jaydeokar AV, Bandawane DD, Bibave KH, Patil TV.

Pharm Biol. 2014 Mar;52(3):344-55. doi: 10.3109/13880209.2013.837075.

PMID:
24472085
8.

Prevention of hepatotoxicity due to anti tuberculosis treatment: a novel integrative approach.

Adhvaryu MR, Reddy N, Vakharia BC.

World J Gastroenterol. 2008 Aug 14;14(30):4753-62.

9.
10.

In vitro effect of N-acetylcysteine on hepatocyte injury caused by dichlorodiphenyltrichloroethane and its metabolites.

van Tonder JJ, Gulumian M, Cromarty AD, Steenkamp V.

Hum Exp Toxicol. 2014 Jan;33(1):41-53. doi: 10.1177/0960327113482954. Epub 2013 Apr 24.

PMID:
23615707
11.

Drug-induced hepatotoxicity of anti-tuberculosis drugs and their serum levels.

Jeong I, Park JS, Cho YJ, Yoon HI, Song J, Lee CT, Lee JH.

J Korean Med Sci. 2015 Feb;30(2):167-72. doi: 10.3346/jkms.2015.30.2.167. Epub 2015 Jan 21.

12.

Protective effect of a 50% hydroalcoholic fruit extract of Emblica officinalis against anti-tuberculosis drugs induced liver toxicity.

Tasduq SA, Kaisar P, Gupta DK, Kapahi BK, Maheshwari HS, Jyotsna S, Johri RK.

Phytother Res. 2005 Mar;19(3):193-7.

PMID:
15934014
13.

Hepatoprotective effect of silymarin on di(2-ethylhexyl)phthalate (DEHP) induced injury in liver FL83B cells.

Lo D, Wang YT, Wu MC.

Environ Toxicol Pharmacol. 2014 Jul;38(1):112-8. doi: 10.1016/j.etap.2014.05.005. Epub 2014 May 27.

PMID:
24934613
14.

Hepatotoxicity due to rifampicin, isoniazid and pyrazinamide in patients with tuberculosis: is anti-HCV a risk factor?

Nader LA, de Mattos AA, Picon PD, Bassanesi SL, De Mattos AZ, Pineiro Rodriguez M.

Ann Hepatol. 2010 Jan-Mar;9(1):70-4.

PMID:
20308724
15.

A study of the effect of Nigella sativa (Black seeds) in isoniazid (INH)-induced hepatotoxicity in rabbits.

Hassan AS, Ahmed JH, Al-Haroon SS.

Indian J Pharmacol. 2012 Nov-Dec;44(6):678-82. doi: 10.4103/0253-7613.103239.

16.

Antituberculosis treatment-induced hepatotoxicity: role of predictive factors.

Singh J, Arora A, Garg PK, Thakur VS, Pande JN, Tandon RK.

Postgrad Med J. 1995 Jun;71(836):359-62.

17.
18.

Acute liver failure due to antitubercular therapy: Strategy for antitubercular treatment before and after liver transplantation.

Ichai P, Saliba F, Antoun F, Azoulay D, Sebagh M, Antonini TM, Escaut L, Delvart V, Castaing D, Samuel D.

Liver Transpl. 2010 Oct;16(10):1136-46. doi: 10.1002/lt.22125.

19.

Hepatotoxicity of pyrazinamide: cohort and case-control analyses.

Chang KC, Leung CC, Yew WW, Lau TY, Tam CM.

Am J Respir Crit Care Med. 2008 Jun 15;177(12):1391-6. doi: 10.1164/rccm.200802-355OC. Epub 2008 Apr 3.

PMID:
18388355
20.

Xanthine oxidase inhibition by allopurinol increases in vitro pyrazinamide-induced hepatotoxicity in HepG2 cells.

Tostmann A, Aarnoutse RE, Peters WH, Richard PN, Boeree MJ.

Drug Chem Toxicol. 2010 Jul;33(3):325-8. doi: 10.3109/01480540903449715.

PMID:
20429806

Supplemental Content

Support Center